X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (185) 185
Publication (22) 22
Book Review (19) 19
Conference Proceeding (3) 3
Newspaper Article (2) 2
Patent (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (133) 133
humans (121) 121
male (83) 83
hiv infections - drug therapy (82) 82
infectious diseases (80) 80
adult (75) 75
female (75) 75
middle aged (52) 52
hiv (46) 46
viral load (43) 43
hiv infections - virology (40) 40
immunology (39) 39
virology (38) 38
microbiology (37) 37
anti-hiv agents - therapeutic use (36) 36
hiv infection (36) 36
treatment outcome (34) 34
cd4 lymphocyte count (32) 32
drug therapy (32) 32
pharmacology & pharmacy (32) 32
aids/hiv (31) 31
drug therapy, combination (30) 30
human immunodeficiency virus--hiv (30) 30
hiv-1 - drug effects (28) 28
antiretroviral therapy (27) 27
antiretroviral drugs (26) 26
hiv infections - immunology (26) 26
aids (25) 25
abridged index medicus (23) 23
antiviral agents (23) 23
anti-hiv agents - administration & dosage (21) 21
hiv protease inhibitors - therapeutic use (21) 21
health aspects (20) 20
hiv-1 (20) 20
aged (19) 19
hiv-1 - genetics (19) 19
rna, viral - blood (19) 19
anti-hiv agents - adverse effects (18) 18
drug resistance, viral (18) 18
infection (18) 18
medicine, general & internal (18) 18
protease inhibitors (17) 17
human immunodeficiency virus (16) 16
life sciences (16) 16
hiv-1-infected patients (15) 15
clinical trials (14) 14
human-immunodeficiency-virus (14) 14
mutation (14) 14
risk factors (14) 14
therapy (14) 14
care and treatment (13) 13
genotype (13) 13
hiv infections - complications (13) 13
resistance (13) 13
reverse transcriptase inhibitors - therapeutic use (13) 13
animals (12) 12
hiv-1 - isolation & purification (12) 12
infections (12) 12
research (12) 12
active antiretroviral therapy (11) 11
anti-hiv agents - pharmacology (11) 11
antiretroviral therapy, highly active (11) 11
drug resistance (11) 11
efficacy (11) 11
hiv protease inhibitors - administration & dosage (11) 11
ritonavir - therapeutic use (11) 11
rna (11) 11
young adult (11) 11
adolescent (10) 10
adults (10) 10
combination therapy (10) 10
disease progression (10) 10
double-blind method (10) 10
follow-up studies (10) 10
hiv-1 - physiology (10) 10
immunodeficiency-virus type-1 (10) 10
treatment failure (10) 10
acquired immune deficiency syndrome--aids (9) 9
analysis (9) 9
antiretroviral therapy, highly active - methods (9) 9
darunavir (9) 9
diagnosis (9) 9
dosage and administration (9) 9
drug administration schedule (9) 9
guidelines (9) 9
prevalence (9) 9
protease inhibitor (9) 9
sulfonamides - therapeutic use (9) 9
cohort studies (8) 8
drug-resistance (8) 8
emtricitabine (8) 8
hiv patients (8) 8
lamivudine (8) 8
patients (8) 8
placebo-controlled trial (8) 8
reverse transcriptase inhibitors - administration & dosage (8) 8
ritonavir - administration & dosage (8) 8
safety (8) 8
time factors (8) 8
viruses (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 5, pp. 510 - 519
Summary Background Listeriosis is a severe foodborne infection and a notifiable disease in France. We did a nationwide prospective study to characterise its... 
Infectious Disease | MORTALITY | MENINGITIS | INFECTIOUS DISEASES | MONOCYTOGENES | RISK-FACTORS | MANAGEMENT | GUIDELINES | SURVEILLANCE | PREGNANCY | Foodborne Diseases - microbiology | Infant, Newborn, Diseases - epidemiology | Prognosis | Prospective Studies | Humans | Listeriosis - diagnosis | Bacteremia - mortality | Male | Infant, Newborn, Diseases - microbiology | Listeriosis - epidemiology | Mandatory Reporting | Listeria monocytogenes - classification | Adult | Female | Pregnancy Complications, Infectious - microbiology | Infant, Newborn | Meningoencephalitis - epidemiology | France - epidemiology | Meningoencephalitis - mortality | Pregnancy Complications, Infectious - epidemiology | Risk Factors | Listeria monocytogenes - isolation & purification | Hospitalization | Infectious Disease Transmission, Vertical | Pregnancy | Meningoencephalitis - microbiology | Bacteremia - epidemiology | Listeriosis - microbiology | Aged | Population Surveillance | Listeriosis | Neonates | Food-borne diseases | Disease | Brain stem | Clinical trials | Infections | Genomes | Gestation | Epidemiology | Risk factors | Windows (intervals) | Listeria | Meningitis | Public health | Food | Dexamethasone | Bacterial infections | Mortality | Fetuses | Regression analysis | Clustering | Patients | Bacteremia | Meningoencephalitis | Studies | Surveillance | Medical prognosis | Health risk assessment | Cancer | Index Medicus | Life Sciences
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0134430 - e0134430
Objective To assess, in a clinical cohort, the efficacy of switching treatment in virologically-suppressed patients to tenofovir/emtricitabine/rilpivirine as a... 
MULTIDISCIPLINARY SCIENCES | DISOPROXIL FUMARATE | EMTRICITABINE | SINGLE-TABLET REGIMEN | RILPIVIRINE | RPV/TDF/FTC | TENOFOVIR | Tenofovir - blood | Follow-Up Studies | Humans | Middle Aged | Emtricitabine, Rilpivirine, Tenofovir Drug Combination - therapeutic use | Male | Tenofovir - administration & dosage | Anti-HIV Agents - administration & dosage | Rilpivirine - therapeutic use | Rilpivirine - blood | Adult | Anti-HIV Agents - therapeutic use | Female | Anti-HIV Agents - blood | Drug Therapy, Combination | Rilpivirine - administration & dosage | Emtricitabine - administration & dosage | Emtricitabine - therapeutic use | Tenofovir - therapeutic use | Emtricitabine, Rilpivirine, Tenofovir Drug Combination - administration & dosage | Emtricitabine - blood | HIV Infections - drug therapy | Drug Substitution | Viral Load - drug effects | Drug Combinations | Virus diseases | Highly active antiretroviral therapy | Care and treatment | Protease inhibitors | Proteases | DNA polymerases | Health aspects | Emtricitabine | Antiretroviral drugs | RNA-directed DNA polymerase | Viremia | Viruses | Proteinase inhibitors | Signal monitoring | Patients | Switching | Chromatography | Antiretroviral therapy | Tenofovir | Non-nucleoside reverse transcriptase inhibitors | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Nucleoside reverse transcriptase inhibitors | Human immunodeficiency virus--HIV | Scientific imaging | Drug therapy | Mass spectrometry | Drug dosages | Genotypes | Index Medicus | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 4, pp. 387 - 396
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 7/2008, Volume 47, Issue 2, pp. 266 - 285
Resistance to antiretroviral drugs remains an important limitation to successful human immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can... 
HIV/AIDS | Antiretrovirals | HIV | Antivirals | Viruses | AIDS | Infections | Drug resistance | Genetic mutation | HIV 1 | Virology | COST-EFFECTIVENESS ANALYSIS | INFECTIOUS DISEASES | SUBTYPE-C PROTEASE | MICROBIOLOGY | IMMUNOLOGY | HUMAN-IMMUNODEFICIENCY-VIRUS | VIROLOGICAL RESPONSE | REVERSE-TRANSCRIPTASE INHIBITORS | INHIBITOR-EXPERIENCED PATIENTS | CLEAVAGE SITE MUTATIONS | FIXED-DOSE COMBINATION | PLACEBO-CONTROLLED TRIAL | TYPE-1 PROTEASE | Anti-HIV Agents - pharmacology | Tropism | HIV-1 - drug effects | HIV Infections - epidemiology | Human Immunodeficiency Virus Proteins - drug effects | Humans | Reverse Transcriptase Inhibitors - pharmacology | Integrase Inhibitors - pharmacology | HIV Fusion Inhibitors - pharmacology | HIV-1 - genetics | Drug Resistance, Viral - physiology | Pregnancy | Protease Inhibitors - pharmacology | HIV-1 - physiology | Treatment Failure | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Human Immunodeficiency Virus Proteins - genetics | Mutation | Microbial Sensitivity Tests - methods | CCR5 Receptor Antagonists | Practice guidelines (Medicine) | Drug resistance in microorganisms | Complications and side effects | Reports | HIV infection | Testing | Antiretroviral drugs | Pharmacology | Drug therapy | Human immunodeficiency virus--HIV | Index Medicus
Journal Article